Biomarkers for Early-Stage Breast Cancer: Clinical Utility for Extended Adjuvant Treatment Decisions

被引：1
|
作者：
Sgroi, Dennis C. [1 ,2 ]
Brufsky, Adam [3 ]
机构：
[1] Massachusetts Gen Hosp, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 32期
关键词：
LATE-DISTANT RECURRENCE; PRACTICE GUIDELINE; AMERICAN SOCIETY; RANDOMIZED-TRIAL; THERAPY; TAMOXIFEN; WOMEN;
D O I：
10.1200/JCO.2016.67.2949
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3941 / +
页数：3
相关论文
共 50 条
  • [11] Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab
    Gollamudi, Jahnavi
    Parvani, Jenny G.
    Schiemann, William P.
    Vinayak, Shaveta
    CANCER MANAGEMENT AND RESEARCH, 2016, 8 : 21 - 31
  • [12] Clinical utility of multigene profiling assays in early-stage breast cancer
    Chang, M. C.
    Souter, L. H.
    Kamel-Reid, S.
    Rutherford, M.
    Bedard, P.
    Trudeau, M.
    Hart, J.
    Eisen, A.
    CURRENT ONCOLOGY, 2017, 24 (05) : E403 - E422
  • [13] Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer
    Corke, L.
    Luzhna, L.
    Willemsma, K.
    Illmann, C.
    Mcdermott, M.
    Wilson, C.
    Simmons, C.
    LeVasseur, N.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (03) : 587 - 595
  • [14] Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer
    L. Corke
    L. Luzhna
    K. Willemsma
    C. Illmann
    M. Mcdermott
    C. Wilson
    C. Simmons
    N. LeVasseur
    Breast Cancer Research and Treatment, 2022, 194 : 587 - 595
  • [15] Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
    Harris, Lyndsay N.
    Ismaila, Nofisat
    McShane, Lisa M.
    Andre, Fabrice
    Collyar, Deborah E.
    Gonzalez-Angulo, Ana M.
    Hammond, Elizabeth H.
    Kuderer, Nicole M.
    Liu, Minetta C.
    Mennel, Robert G.
    Van Poznak, Catherine
    Bast, Robert C.
    Hayes, Daniel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) : 1134 - +
  • [16] Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update
    Andre, Fabrice
    Ismaila, Nofisat
    Allison, Kimberly H.
    Barlow, William E.
    Collyar, Deborah E.
    Damodaran, Senthil
    Henry, N. Lynn
    Jhaveri, Komal
    Kalinsky, Kevin
    Kuderer, Nicole M.
    Litvak, Anya
    Mayer, Erica L.
    Pusztai, Lajos
    Raab, Rachel
    Wolff, Antonio C.
    Stearns, Vered
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : 1816 - +
  • [17] Adjuvant Treatment for Early-stage Endometrial Cancer
    Zighelboim, Israel
    Powell, Matthew A.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2011, 54 (02): : 245 - 255
  • [18] Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update Summary
    Andre, Fabrice
    Ismaila, Nofisat
    Stearns, Vered
    JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (09) : 495 - +
  • [19] Utility Scores and Treatment Preferences for Clinical Early-Stage Cervical Cancer
    Jewell, Elizabeth L.
    Smrtka, Michael
    Broadwater, Gloria
    Valea, Fidel
    Davis, Debra M.
    Nolte, Kimberly C.
    Valea, Renea
    Myers, Evan R.
    Samsa, Gregory
    Havrilesky, Laura J.
    VALUE IN HEALTH, 2011, 14 (04) : 582 - 586
  • [20] Optimizing adjuvant chemotherapy in early-stage breast cancer
    Perez, Edith
    Muss, Hyman B.
    ONCOLOGY-NEW YORK, 2005, 19 (14): : 1759 - 1767
12345